Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Thyroid Disorders
•
Primary Care
How long should T3 be continued in hypothyroid patients who received no symptomatic benefit after starting T3/T4 combination therapy?
Answer from: at Community Practice
I stop at next visit and increase T4 replacement accordingly.
Sign In
or
Register
to read more
Answer from: at Community Practice
If no side effects, I ask them to continue it until 6-12 weeks before fully stopping it. Sometimes, they notice they were better with it after they stop it. But most just stop it.
Sign In
or
Register
to read more
19606
20297
Related Questions
Would you increase or maintain the same initial dose of methimazole for treatment of hyperthyroidism if symptoms and thyroid tests improve but are not normalized?
How often should TSH levels be monitored in patients with a history of Graves' disease who are in remission with negative TSI/TBII antibodies and off medical therapy?
How do you approach treatment of depression in Graves' Disease?
How do you assess and adjust treatment in patients who develops hypothyroidism after being on lithium for several years?
Is a target TSH closer to the mid normal range justified in older individuals (age 70 or above) without any known cardiac ischemia or dysrhythmia or osteoporosis?
Do you recommend checking both TSI and TBII antibodies for Graves' disease diagnosis and monitoring?
How often do you recommend performing an advanced lipid panel for monitoring of lipid lowering therapy?
How long do you recommend waiting to repeat an ultrasound in patients with cytologically benign thyroid nodules and very low to intermediate suspicion ultrasound patterns?
How do you counsel patients on the likelihood of resolution of their hypertension post adrenalectomy for primary hyperaldosteronism?
How do you counsel breastfeeding women on their limitations post radioactive iodine ablation for thyroid cancer treatment?